Showing results (21-30 of 83) with videos related to

Sort By:
Pageof 9
The Journal of Urology|July 17, 2007
Docetaxel and cisplatin in patients with metastatic androgen independent prostate cancer and circulating neuroendocrine markersStéphane Culine, Mounira El Demery, Pierre-Jean Lamy, et al.
Presse Medicale (Paris, France : 1983)|October 17, 2017
[Rates of total and free PSA prescriptions in France (2012-2014)]Philippe Tuppin, Claire Leboucher, Gabrielle Peyre-Lanquar, et al.
American Journal of Clinical Pathology|August 22, 2007
Urokinase-type plasminogen activator and plasminogen activator inhibitor type-1 mRNA assessment in breast cancer by means of NASBA: correlation with protein expressionPierre-Jean Lamy, Thibault Verjat, Anne-Claire Servanton, et al.
Cancer Medicine|January 4, 2024
Sexually and non-sexually transmitted infections and the risk of prostate cancer: Results from the EPICAP studyMelissa Sawaya, Emilie Cordina-Duverger, Pierre-Jean Lamy, et al.
Breast Cancer Research and Treatment|November 1, 2002
Progesterone receptor quantification as a strong prognostic determinant in postmenopausal breast cancer women under tamoxifen therapyPierre-Jean Lamy, Pascal Pujol, Simon Thezenas, et al.
Lung Cancer (Amsterdam, Netherlands)|February 13, 2003
Neuroendocrine and cytokeratin serum markers as prognostic determinants of small cell lung cancerJean-Louis Pujol, Xavier Quantin, William Jacot, et al.
Breast Cancer Research and Treatment|May 8, 2012
Increased prevalence of vitamin D insufficiency in patients with breast cancer after neoadjuvant chemotherapyWilliam Jacot, Stéphane Pouderoux, Simon Thezenas, et al.
Clinical Chemistry and Laboratory Medicine|December 27, 2005
NASBA: a novel approach to assess hormonal receptors and ERBB2 status in breast cancerPierre-Jean Lamy, Thibault Verjat, Malick Paye, et al.
Cancer Epidemiology|October 24, 2022
Diabetes, metabolic syndrome and prostate cancer risk: Results from the EPICAP case-control studyCéline Lavalette, Emilie Cordina-Duverger, Xavier Rébillard, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 6, 2022
Sleep Patterns and Risk of Prostate Cancer: A Population-Based Case Control Study in France (EPICAP)Emilie Cordina-Duverger, Sylvie Cénée, Brigitte Trétarre, et al.
Pageof 9